Ovarian Cancer Screening: Resist the Temptation -- For Now

medscape


Ovarian cancer continues to be the most lethal gynecologic malignancy. Currently, screening for this disease in average-risk women is not recommended owing to a high rate of false-positive test results that lead to unnecessary surgery.^[1]
In an April 2009 commentary, I summarized initial findings from a British trial^[2] of ovarian cancer screening in more than 200,000 postmenopausal women. Six years later, these UK investigators have reported their preliminary findings with respect to impact on mortality.^[3]......Although the road forward continues to be challenging, this trial's findings bring us one step closer to routine screening for ovarian cancer.